FLT3 overexpression
|
Multiple Myeloma
|
FLT3 overexpression
|
Multiple Myeloma
|
gilteritinib Sensitive: D – Preclinical
|
gilteritinib Sensitive: D – Preclinical
|
FLT3 overexpression
|
AML
|
FLT3 overexpression
|
AML
|
midostaurin Resistant: D – Preclinical
|
midostaurin Resistant: D – Preclinical
|